Abstract:To date, several on-treatment-level virological and serological indices that may predict the response to interferon alpha (IFN-alpha) have been reported. However, no effective predictors, such as drug-response genes, that can be detected before administration of anti-hepatitis B virus (HBV) therapy with IFN-a, have been found. In the diverse range of chronic viral infection, genes that affect human immunity play important roles in understanding host and viral co-evolution. Killer-cell immunoglobulin-like receptors (KIRs), which are highly polymorphic at the allele and haplotype levels, participate in the antiviral function of natural killer (NK) cells via fine-tuning inhibition and activation of NK-cell responses that occur when the NK cells interact with human leukocyte antigen (HLA) class I molecules on target cells. For each individual, the pairing of KIR and HLA ligand is genetically determined. To investigate whether a particular KIR and HLA repertoire influences the risk of HBV infection and response to IFN-alpha treatment for chronic hepatitis B (CHB), we genotyped the KIRs and HLA ligands of 119 hepatitis B e antigen (HBeAg)-positive CHB patients. These patients included 43 patients who achieved sustained response (SR) induced by IFN-alpha treatment for 48 weeks, 76 patients who achieved no response (NR), and 96 healthy subjects as controls. SR was defined as HBeAg loss with HBV DNA < 2,000 IU/ml and alanine aminotransferase normalization at 24 weeks posttreatment (week 72). In this study, we showed that activating KIR genes were less prevalent in Han Chinese, especially in Han Chinese with CHB, than in Caucasians. Furthermore, the KIR3DS1 gene, in combination with HLA-B Bw4-80Ile, strongly influenced the therapeutic outcomes for CHB patients who were treated with IFN-alpha. The frequency of the combination of genes encoding KIR3DS1 and HLA-B Bw4-80Ile was higher in patients who had a sustained treatment response than in patients who had NR [35.3 versus 1.3%; odds ratio (OR) = 19.85; P = 0.0008]. Activating KIR3DS1 and HLA-B Bw4-80Ile synergistically predicted SR to IFN-a for HBeAg-positive CHB patients. Genotyping for the KIR3DS1 gene and the HLA-B Bw4-80Ile allele might help physicians choose the optimal candidates for anti-HBV treatment with IFN-alpha.

The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study)

Epidemiological Characteristics of the Carriers with Coexistence of Hbsag and Anti-Hbs Based on A Community Cohort Study

Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Genetic Variants in KIR/HLA-C Genes Are Associated With the Susceptibility to HCV Infection in a High-Risk Chinese Population

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

Novel Host Genetic Variations Associated with Spontaneous Clearance of A Single-Source Outbreak of Hcv1b Infections

HLA Class I and KIR Genes Do Not Protect Against HIV Type 1 Infection in Highly Exposed Uninfected Individuals with Hemophilia A.

The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-infected and HIV-uninfected Women.

HLA-Cw*04 and hepatitis C virus persistence.

Risk Of Classic Kaposi Sarcoma With Combinations Of Killer Immunoglobulin-Like Receptor And Human Leukocyte Antigen Loci: A Population-Based Case-Control Study

Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy

KIR3DS1/HLA-B Bw4-80Ile Genotype is Correlated with the IFN-α Therapy Response in Hepatitis B E Antigen-Positive Chronic Hepatitis B

Association between killer cell immunoglobulin-like receptor/human leukocyte antigen gene polymorphisms and sporadic acute hepatitis E

HCV infection and how HCV RNA load and genotype influence the natural history of HIV-1 disease

High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients

The deleterious effect of the HLA-C1/KIR2DL3 receptor-ligand combination in Chinese HIV patients

Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort

KIR/HLA Compound Genotypes Determine Early Antiviral Response of Natural Killer Cells (35.17)

Association Between CISH Polymorphisms and Spontaneous Clearance of Hepatitis B Virus in Hepatitis B Extracellular Antigen–positive Patients During Immune Active Phase